Valuation Beijing Beilu Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. Other stock markets 2026-07-27			5-day change	1st Jan Change
7.840 ^CNY	+6.09%		+2.48%	-1.26%

04-28	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-26	Beijing Beilu Pharmaceutical Co., Ltd. announced that it has received CNY 159 million in funding from a group of investors	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	4,727	4,523	3,208	3,503	3,050	4,469
Change	-	-4.32%	-29.09%	9.2%	-12.92%	46.53%
Enterprise Value (EV) ¹	4,417	4,204	3,088	3,545	3,239	4,300
Change	-	-4.82%	-26.55%	14.81%	-8.63%	32.77%
P/E	26.6x	36.7x	326x	-47.5x	207x	44.1x
PBR	2.71x	2.44x	1.81x	2.12x	1.83x	1.98x
PEG	-	-1.2x	-3.5x	0x	-2x	0x
Capitalization / Revenue	5.71x	5.36x	4.19x	3.93x	3.1x	3.71x
EV / Revenue	5.34x	4.98x	4.03x	3.98x	3.29x	3.57x
EV / EBITDA	24.6x	24.2x	44.7x	150x	22.6x	23.5x
EV / EBIT	32.2x	37.7x	-603x	-62.4x	60.8x	48.9x
EV / FCF	-1,039x	-34.3x	-52.9x	-20.1x	-134x	-25.5x
FCF Yield	-0.1%	-2.92%	-1.89%	-4.97%	-0.75%	-3.93%
Dividend per Share ²	0.06	0.07	0.07	-	0.05	-
Rate of return	0.63%	0.76%	1.07%	-	0.81%	-
EPS ²	0.36	0.25	0.02	-0.15	0.03	0.18
Distribution rate	16.7%	28%	350%	-	167%	-
Net sales ¹	827.3	843.9	765.9	890.7	983.6	1,205
EBITDA ¹	179.7	173.6	69.09	23.6	143.4	182.7
EBIT ¹	137.3	111.4	-5.124	-56.82	53.24	87.86
Net income ¹	174.7	125	11.21	-71.76	13.65	92.73
Net Debt ¹	-310.6	-319.3	-120	42.28	189.1	-168.8
Reference price ²	9.560	9.180	6.520	7.120	6.200	7.940
Nbr of stocks (in thousands)	494,494	492,718	491,956	491,935	491,935	562,873
Announcement Date	3/18/21	3/29/22	4/23/23	4/21/24	4/17/25	4/21/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BEIJING BEILU PHARMACEUTICAL CO., LTD.	-	-	-	-	673M
ELI LILLY AND COMPANY	35.56x	12.7x	26.67x	0.56%	1,068B
JOHNSON & JOHNSON	28.51x	6.52x	18.04x	2.02%	641B
ABBVIE INC.	32.33x	7.59x	15.6x	2.68%	454B
ROCHE HOLDING AG	19.49x	4.75x	11.79x	2.78%	351B
NOVARTIS AG	22.29x	5.76x	14.37x	2.78%	299B
ASTRAZENECA PLC	21.47x	4.5x	12.72x	1.93%	266B
NOVO NORDISK A/S	14.4x	5.35x	11.02x	3.48%	220B
AMGEN INC.	24.71x	6.49x	11.44x	2.68%	203B
GILEAD SCIENCES, INC.	-47.03x	5.64x	31.15x	2.53%	162B
Average	16.86x	6.59x	16.98x	2.38%	366.4B
Weighted average by Cap.	24.76x	7.96x	18.76x	1.95%